Could a VR headset ease sickle cell pain?
NCT ID NCT07674277
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study explores whether using a virtual reality headset can help reduce pain for adults with sickle cell disease during a painful crisis. Participants will try different types of headset experiences—like watching a 2D video or exploring a 3D world—during their infusion center visits. Researchers will measure pain levels and how well people tolerate the headset to see if this approach is worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- virtual reality headset
- What this could lead to
- If effective, virtual reality could offer a drug-free way to reduce pain during sickle cell crises, potentially lowering opioid use.
- What could go wrong
- This is a small pilot study with only 25 participants, so results may not apply broadly. The effect on pain may be minimal or no better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Maryland Medical Center, Stoler Infusion Center
Baltimore, Maryland, 21230, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Co-Designed support help parents embrace sickle cell care?
- Can community hospitals in zambia master severe disease care?
- A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?
- Can a phone app keep teens on track with sickle cell treatment?
- A common amino acid may calm sickle cell pain crises — a trial puts it to the test
- A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease